Top

Intensive Care Medicine

Published in:

01-05-2008 | Original

Intensive care unit acquired infection and organ failure

Authors: Pierre Damas, Didier Ledoux, Monique Nys, Mehran Monchi, Patricia Wiesen, Benoît Beauve, Jean-Charles Preiser

Published in: Intensive Care Medicine | Issue 5/2008

Abstract

Objective

To assess the temporal relationship between ICU-acquired infection (IAI) and the prevalence and severity of organ dysfunction or failure (OD/F).

Design and setting

Observational, single center study in a mixed intensive care unit of a university hospital.

Patients

We analyzed 1,191 patients hospitalized for more than 2 days during a 2-year observation period: 845 did not acquire IAI, 306 of whom had infection on admission (IOA); 346 did acquire IAI, 125 of whom had IOA.

Measurements and results

The SOFA score was calculated daily, both SOFAmax, the sum of the worst OD/F during the ICU stay, and SOFApreinf, the sum of the worst OD/F existing before the occurrence of the first IAI. The SAPS II and SOFA score of the first 24 h were significantly higher in patients with than in those without IAI. SOFApreinf of IAI patients was also higher than the SOFAmax of patients without IAI both in patients with (12.1 ± 4.6 vs. 8.9 ± 4.7) and those without IOA (9.2 ± 4.0 vs. 6.7 ± 3.5). SOFApreinf represented 85.7% of the value of SOFAmax in patients with IAI. SOFApreinf increased significantly with the occurrence of sepsis, severe sepsis, or septic shock during ICU stay. Severe sepsis and septic shock during ICU stay as well as SOFApreinf were part of the factors associated with hospital mortality.

Conclusions

IAI is significantly associated with hospital mortality; however, its contribution to OD/F is minor. Moreover, severity of IAI seems to be related to previous health status.

Pittet D, Herwaldt L, Massanari R (1992) The intensive care unit. In: Bennett JV, Brachman PS (ed) Hospital infection, 3rd edn. Little Brown, Boston, pp 405–439

Smith RL (2006) Prevention of infection in the intensive care unit. Curr Opin Infect Dis 19:323–326PubMedCrossRef

Bearman GM, Munro C, Sessler CN, Wenzel RP (2006) Infection control and the prevention of nosocomial infections in the intensive care unit. Semin Respir Crit Care Med 27:310–324PubMedCrossRef

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee (1992) American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864–874CrossRef

Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Sutter PM, Thijs LG (1996) The SOFA (Sepsis-related organ failure assessment) score to describe organ dysfunction/failure. Intensive Care Med 22:707–710PubMedCrossRef

Vincent JL, De Mendonca A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S (1998) Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicentric, prospective study. Crit Care Med 26:1793–1800PubMed

Brun-Buisson C, Meshaka P, Pinton P, Vallet B; The EPISEPSIS Study Group (2004) EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med 30:580–588PubMedCrossRef

Vincent JL, Sakr Y, Sprung CH, Ranieri M, Reinhart K, Gerlach H, Moreno R, Carlet J, Legall JR, Payen D (2006) Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 34:344–353PubMedCrossRef

Angus D, Linde-Zwirble W, Lidicker J, Clermont G, Carcillo J, Pinsky M (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303–1310PubMedCrossRef

10.

Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United states from 1979 through 2000. N Engl J Med 348:1546–1554PubMedCrossRef

11.

Moreno R, Vincent JL, Matos R, Mendonca A, Cantraine F, Thijs L, Takala J, Sprung C, Antonelli M, Bruining H, Willatts S (1999) The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Intensive Care Med 25:686–696PubMedCrossRef

12.

McCabe WR, Jackson GG (1962) Gram-negative bacteraemia, aetiology and ecology. Arch Intern Med 110:845–853

13.

Alberti C, Brun-Buisson C, Goodman SV, Guidici D, Granton J, Moreno R, Smithies M, Thomas O, Artigas A, Le Gall JR (2003) Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients. Am J Respir Crit Care Med 168:77–84PubMedCrossRef

14.

Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP (1995) The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273:117–123PubMedCrossRef

15.

Alberti C, Brun-Buisson C, Burchardi H, Martin C, Goodman S, Artigas A, Sicignano A, Palazzo M, Moreno R, Boulme R, Lepage E, Le Gall R (2002) Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 28:108–121PubMedCrossRef

16.

Gerard C (2003) Complement C5a in the sepsis syndrome—too much of a good thing? N Engl J Med 348:167–169PubMedCrossRef

17.

Oberholzer A, Souza SM, Tschoeke SK, Oberholzer C, Abouhamze A, Pribble JP, Moldawer LL (2005) Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis. Shock 23:488–493PubMed

18.

Engel C, Brunkhorst FM, Bone HG, Brunkhorst R, Gerlach H, Grond S, Gruendling M, Huhle G, Jachinski U, John S, Mayer K, Oppert M, Olthoff D, Quintel M, Ragaller M, Rossaint R, Stuber F, Weiler N, Welte T, Bogatsch H, Hartog C, Loeffler M, Reinhart K (2007) Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Med 33:606–618PubMedCrossRef

19.

Kooi T van der, de Boer A, Manniën J, Wille J, Beaumont M, Mooi B, van den Hof S (2007) Incidence and risk factors of device-associated infection and associated mortality at the intensive care in the Dutch surveillance system. Intensive Care Med DOI 10.1007/s00134-006-0464-3

Title: Intensive care unit acquired infection and organ failure
Authors: Pierre Damas
Didier Ledoux
Monique Nys
Mehran Monchi
Patricia Wiesen
Benoît Beauve
Jean-Charles Preiser
Publication date: 01-05-2008
Publisher: Springer-Verlag
Published in: Intensive Care Medicine / Issue 5/2008
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-008-1018-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Intensive care unit acquired infection and organ failure

Abstract

Objective

Design and setting

Patients

Measurements and results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objective

Design and setting

Patients

Measurements and results

Conclusions

Please log in to get access to this content

Other articles of this Issue 5/2008

ICU-acquired infections and Sepsis: More of a deadly duo

Acute respiratory failure: back to the roots!

Cardiorenal syndrome: refining the definition of a complex symbiosis gone wrong

Use of recombinant human activated protein C in patients with severe sepsis: a French retrospective multicentre study

Early versus late intravenous insulin administration in critically ill patients

Assessment of severity in patients with community-acquired pneumonia: reply to letter by Challen et al.